J.P. Morgan will advise NeuroRx
January 4, 2018
WILMINGTON– NeuroRx, a Wilmington clinical stage biopharma company developing the first drug regimen to treat severe bipolar depression, has retained J.P. Morgan as financial advisor. NeuroRx will begin enrolling patients […]
chat_bubble0 Comment
visibility673 Views
Suicide drug gets FDA fast track
September 8, 2017
NeuroRx, a Wilmington biopharmaceutical company, has been granted fast-track status by the U.S. Food and Drug Administration for an experimental treatment for suicidal behavior. The company will begin enrolling patients […]
chat_bubble0 Comment
visibility525 Views
Premier Digital Partners
© 2023 Delaware Business Times